Royal Bank Of Canada In Med Pharmaceuticals Inc. Transaction History
Royal Bank Of Canada
- $471 Billion
- Q3 2024
A detailed history of Royal Bank Of Canada transactions in In Med Pharmaceuticals Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 24 shares of INM stock, worth $111. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24
Previous 25
4.0%
Holding current value
$111
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding INM
# of Institutions
16Shares Held
1.14MCall Options Held
0Put Options Held
0-
Advisor Shares Investments LLC Bethesda, MD733KShares$3.42 Million0.03% of portfolio
-
Ubs Group Ag212KShares$988,1010.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il56.7KShares$264,0630.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny50.3KShares$234,3790.0% of portfolio
-
Hrt Financial LP New York, NY38.4KShares$178,7990.0% of portfolio
About InMed Pharmaceuticals Inc.
- Ticker INM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 908,761
- Market Cap $4.23M
- Description
- InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...